Contents
On the medicine shelf, a GI cancer question usually hands you a risk factor and one physical finding (a smoker with painless jaundice, a man with iron deficiency anemia, a patient with cirrhosis and a new liver nodule) and asks for the first test. The cancer is rarely in doubt. The order of tests is what gets scored.
GI cancers at a glance
| Cancer | Biggest risk factors | Classic stem | First diagnostic test | Pearl |
|---|---|---|---|---|
| Esophageal adenocarcinoma | Chronic GERD, Barrett esophagus, obesity, smoking | Older man, progressive dysphagia to solids then liquids, weight loss | Upper endoscopy with biopsy | Distal third of the esophagus |
| Esophageal squamous cell carcinoma | Smoking, heavy alcohol use, achalasia, caustic injury | Same dysphagia pattern, upper or middle esophagus | Upper endoscopy with biopsy | The most common type worldwide |
| Gastric adenocarcinoma | H. pylori, smoked and salted foods, smoking, germline CDH1 (diffuse type) | Early satiety, weight loss, left supraclavicular node, periumbilical nodule | Upper endoscopy with biopsy | Diffuse type: signet ring cells, linitis plastica |
| Pancreatic adenocarcinoma | Smoking, chronic pancreatitis, obesity, diabetes, family history, BRCA variants | Painless jaundice, weight loss, palpable nontender gallbladder, migratory thrombophlebitis | Pancreatic-protocol (multiphase) CT | CA 19-9 tracks the disease; it does not make the diagnosis |
| Hepatocellular carcinoma | Cirrhosis from any cause, hepatitis B even without cirrhosis, hepatitis C, alcohol, MASLD | Patient with cirrhosis who decompensates, or a new nodule on surveillance ultrasound | Multiphase CT or MRI | Arterial enhancement with washout is diagnostic without biopsy |
| Cholangiocarcinoma | Primary sclerosing cholangitis, liver flukes, choledochal cyst | Painless jaundice with a hilar stricture, often in a patient with ulcerative colitis | MRI with MRCP | ERCP with brushings gives tissue and drainage |
| Gallbladder carcinoma | Gallstones, porcelain gallbladder, large polyps, PSC | Found at cholecystectomy, or RUQ pain with weight loss | Ultrasound, then CT | In PSC, a gallbladder polyp larger than 8 mm goes to cholecystectomy |
| Colorectal adenocarcinoma | Age, adenomas, inflammatory bowel disease, Lynch syndrome, FAP | Right side: iron deficiency anemia. Left side: hematochezia, narrow stools, obstruction | Colonoscopy with biopsy | Streptococcus gallolyticus bacteremia calls for a colonoscopy |
The approach to painless jaundice
Painless jaundice in an older adult is cancer until proven otherwise. The sequence below is what the shelf rewards.
- Confirm a cholestatic patternRaised direct bilirubin and alkaline phosphatase out of proportion to the aminotransferases.
- Right upper quadrant ultrasoundLook for dilated bile ducts and stones. Dilated ducts without stones point to a distal obstruction.
- Pancreatic-protocol CT for a distal obstructionMultiphase CT shows the mass, its relation to the mesenteric vessels and any liver metastases, which decides resectability.
- No mass on CT but high suspicion: endoscopic ultrasoundEUS finds small tumors that CT misses and allows fine-needle biopsy when tissue is needed.
- Hilar stricture: MRI with MRCP, then ERCPMRCP maps the ducts; ERCP adds brushings for cytology and a stent for drainage. This is the cholangiocarcinoma path.
- Use CA 19-9 lastIt supports the picture and tracks treatment response, but benign biliary obstruction also raises it.
The work-up of iron deficiency anemia in an older adult
In a man or a postmenopausal woman, iron deficiency anemia means GI blood loss until proven otherwise. The 2020 AGA guideline sets the steps.
- Confirm iron deficiencyAGA uses a ferritin cutoff of 45 ng/mL to diagnose iron deficiency.
- Bidirectional endoscopyUpper endoscopy and colonoscopy for asymptomatic men and postmenopausal women with iron deficiency anemia.
- Celiac serology before duodenal biopsyIn asymptomatic adults, AGA suggests noninvasive celiac testing first and biopsy only if it is positive.
- Test for H. pylori and treat if positiveNoninvasive testing is suggested as part of the evaluation.
Never accept diet or a low-grade cause as the explanation in this group without endoscopy. A right-sided colon cancer often presents with anemia and nothing else.
Treatment pearls the shelf still asks
- Advanced hepatocellular carcinoma: first-line systemic therapy is atezolizumab plus bevacizumab or durvalumab plus tremelimumab (AASLD 2023). Sorafenib is no longer the first-line answer.
- Small HCC within transplant criteria in decompensated cirrhosis: liver transplant evaluation. Resection is for patients with preserved liver function.
- Resectable pancreatic cancer: surgery with adjuvant chemotherapy (modified FOLFIRINOX for fit patients), or neoadjuvant therapy first. Offer germline genetic testing to every patient.
- Low-grade gastric MALT lymphoma with H. pylori: eradication therapy first.
- Colorectal cancer after resection: CEA is for surveillance, not for screening.
Clue in the stem, next best step
| Clue in the stem | What it points to | Next best step |
|---|---|---|
| 70-year-old man, hemoglobin 9.8 g/dL, ferritin 6 ng/mL, no GI symptoms | Iron deficiency anemia from occult GI loss | Upper endoscopy and colonoscopy |
| Painless jaundice, palpable nontender gallbladder, dilated ducts without stones | Periampullary or pancreatic head mass | Pancreatic-protocol CT |
| CT negative, persistent obstruction and weight loss | Small pancreatic tumor | Endoscopic ultrasound |
| Recurrent superficial venous clots in different veins, weight loss | Trousseau syndrome | Look for an occult cancer, pancreatic first |
| Cirrhosis, new 2.5 cm nodule on ultrasound | Possible HCC | Multiphase CT or MRI |
| Streptococcus gallolyticus endocarditis | Colonic neoplasm | Colonoscopy |
| Ulcerative colitis, cholestatic labs, hilar stricture | Cholangiocarcinoma in PSC | MRCP, then ERCP with brushings |
| Early satiety, weight loss, hard left supraclavicular node | Gastric cancer | Upper endoscopy with biopsy |
Where students lose points
- Ordering CA 19-9, CEA or AFP to diagnose a cancer. Markers support imaging and track treatment; they do not replace a diagnostic test.
- Choosing ERCP as the first test for painless jaundice. Imaging comes first; ERCP is for tissue, brushings or drainage.
- Stopping at colonoscopy for iron deficiency anemia. Both the upper and lower GI tract are examined.
- Biopsying a liver nodule that already meets imaging criteria for HCC.
- Assuming no cirrhosis means no HCC risk. Hepatitis B can cause HCC in a noncirrhotic liver.
- Listing sorafenib as first-line therapy for advanced HCC. Immunotherapy combinations replaced it.
Practice question
A 67-year-old man comes to the physician because of yellow skin and dark urine for 2 weeks. He has lost 6 kg over 3 months without trying. He has no abdominal pain or fever. He has smoked 1 pack of cigarettes daily for 40 years and was diagnosed with type 2 diabetes 6 months ago. Temperature is 37.0 C. He is jaundiced. A nontender, distended gallbladder is palpable in the right upper quadrant. Total bilirubin is 9.2 mg/dL (direct 7.8 mg/dL), alkaline phosphatase 610 U/L, AST 88 U/L and ALT 102 U/L. Ultrasound shows dilated intrahepatic and extrahepatic bile ducts and a dilated pancreatic duct, with no gallstones.
Which of the following is the most appropriate next step in diagnosis?
- Serum CA 19-9
- Hepatobiliary iminodiacetic acid scan
- Multiphase pancreatic-protocol CT of the abdomen
- ERCP with biliary stent placement
- Laparoscopic cholecystectomy
Show the answer
Answer: C. Painless jaundice, weight loss, new diabetes and a palpable nontender gallbladder with a dilated bile duct and pancreatic duct (the double duct sign) point to a pancreatic head cancer. Multiphase CT confirms the mass and stages it, including vascular involvement, which decides whether it can be resected.
Why the others are wrong. A: CA 19-9 supports the diagnosis and is used for monitoring, but obstructive jaundice alone can raise it. B: a HIDA scan evaluates acute cholecystitis, not a painless obstruction. D: ERCP is for drainage or tissue once imaging defines the lesion; routine preoperative stenting is not the first step. E: the gallbladder is distended because of a distal obstruction, not gallbladder disease.
60-second recall
Say each answer out loud before you reveal it, then mark yourself. Retrieval, not rereading, is what makes it stick.
1First test for dysphagia with weight loss
Upper endoscopy with biopsy.Did you get it?2First test for painless jaundice with dilated ducts and no stones
Pancreatic-protocol CT.Did you get it?3CT negative but high suspicion for pancreatic cancer
Endoscopic ultrasound.Did you get it?4HCC on imaging
Arterial enhancement plus washout; no biopsy needed.Did you get it?5Iron deficiency anemia in an older adult
Ferritin under 45 ng/mL, then EGD and colonoscopy.Did you get it?6Advanced HCC first-line
Atezolizumab plus bevacizumab, or durvalumab plus tremelimumab.Did you get it?
Make retrieval a habit on every topic with Learning to Learn Medicine. Module 1 is free; the full bundle (the course plus all 12 Recall Labs) is a one-time $199.
Next: browse every Board Review post, review the GI cancer progression pathways, or see MedRise for students.
Sources
- Ko CW, et al. AGA clinical practice guidelines on the gastrointestinal evaluation of iron deficiency anemia. Gastroenterology, 2020 (PubMed 32810434)
- Park W, Chawla A, O'Reilly EM. Pancreatic cancer: a review. JAMA, 2021 (PubMed 34547082)
- Singal AG, et al. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology, 2023 (PubMed 37199193)
- Bowlus CL, et al. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology, 2023 (PubMed 36083140)
- Shaheen NJ, et al. Diagnosis and management of Barrett's esophagus: an updated ACG guideline. Am J Gastroenterol, 2022 (PubMed 35354777)
- Chey WD, et al. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol, 2024 (PubMed 39626064)
- US Preventive Services Task Force. Colorectal cancer: screening. Final recommendation statement, 2021
MedRise Board Review is educational content for exam preparation only. It is not medical advice and does not replace current guidelines, your school's materials or clinical judgment.



